CISPLATIN INJECTION BP
CISPLATIN INJECTION BP
Approved
DIN Number
02536285
Drug Class
Human
Market Date
Feb 23, 2024
Company
HC
hikma canada limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02536285
AIG Number0113245002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01XA01 CISPLATIN
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
CISPLATINActive
Strength: 1 MG / ML
Monograph: CISPLATIN